Attached files
| file | filename |
|---|---|
| 10-Q - QUARTERLY REPORT - Silo Pharma, Inc. | f10q0314_pointcapital.htm |
| EX-32.1 - CERTIFICATIONS - Silo Pharma, Inc. | f10q0314ex32i_pointcapital.htm |
| EX-31.1 - CERTIFICATIONS - Silo Pharma, Inc. | f10q0314ex31i_pointcapital.htm |
| EX-31.2 - CERTIFICATIONS - Silo Pharma, Inc. | f10q0314ex31ii_pointcapital.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Vadim Mats, Chief Financial Officer of Point Capital, Inc. (the “Registrant”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Registrant for the quarter ended March 31, 2014 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: May 2, 2014
| By: | /s/ Vadim Mats |
|
|
Vadim Mats
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.